Walleye Capital’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Walleye Capital’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-105,000	Closed	-$1.93K	–	1590
2020 Q4	$1.93K	Buy	105,000 +14,334	+16%	+$261K	0.13%	131
2020 Q3	$1.66M	Buy	+90,666	New	+$1.52M	0.19%	145

Walleye Capital's CBMG Position: Q1 2021 in Review

Walleye Capital sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 105,000 shares — an estimated $1.93K sold.

Walleye Capital first reported a position in CBMG in Q3 2020 and held it in 2 quarters. The position peaked at $1.66M in Q3 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

Walleye Capital reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
Walleye Capital sold 105,000 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $1.93K.
Walleye Capital first reported a position in Cellular Biomedicine Group, Inc. in Q3 2020 and held it in 2 quarters.
Walleye Capital's Cellular Biomedicine Group, Inc. position peaked at $1.66M in Q3 2020.
0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Walleye Capital's 13F filing for Q1 2021, filed 17 May 2021.